Drug and Alcohol Dependence

Pathological gambling among methadone patients
pp. 75-81(7)
Authors: Feigelman W.; Kleinman P.H.; Lesieur H.R.; Millman R.B.; Lesser M.L.

-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: pharmacological evaluation and interaction with methamphetamine
pp. 83-89(7)
Authors: Moore K.A.; Lichtman A.H.; Poklis A.; Borzelleca J.F.

Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors
pp. 91-98(8)
Authors: Greenfield L.; Bigelow G.E.; Brooner R.K.

Construct validity of the abuse-dependence distinction as measured by DSM-IV criteria for different psychoactive substances
pp. 99-109(11)
Authors: Feingold A.; Rounsaville B.

DSM-III-R alcohol abuse and dependence and psychiatric comorbidity in Ontario: results from the Mental Health Supplement to the Ontario Health Survey
pp. 111-128(18)
Author: Ross H.E.

Common genetic mechanisms in alcohol, drug, and mental disorder comorbidity
pp. 129-138(10)
Authors: Pickens R.W.; Svikis D.S.; McGue M.; LaBuda M.C.

DSM-III, DSM-IV and ICD-10 as severity scales for drug dependence
pp. 139-150(12)
Authors: Langenbucher J.W.; Morgenstern J.; Miller K.J.

Assessment of nalmefene glucuronide as a selective gut opioid antagonist
pp. 151-154(4)
Authors: Cheskin L.J.; Chami T.N.; Johnson R.E.; Jaffe J.H.

The role of dopamine in drug abuse viewed from the perspective of its role in motivation
pp. 155-155(1)
Author: Di Chiara G.